Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Publisher’s Statement: Raising Cain
1
x
$
0.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
1
x
$
0.00
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
1
x
$
30.00
Haim Einat, PhD: New Approaches to Modeling Bipolar Disorder
1
x
$
30.00
Sati Mazumdar, PhD: Survival Models With Time-Varying Coefficients: A Flexible Approach to the Analysis of Psychiatric Survival Data
1
x
$
30.00
Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood
1
x
$
30.00
Flavonoids Join the War on Cancer
1
x
$
0.00
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
C. Lindsay DeVane, PharmD: Clinical Significance of Drug Binding, Protein Binding, and Binding Displacement Drug Interactions
1
x
$
30.00
Marcia L. Verduin, MD: Psychosis and Delirium Following Metabolife Use
1
x
$
30.00
Antidepressant Induced Apathy Responsive to Dose Reduction
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
1
x
$
0.00
Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression
1
x
$
30.00
View Cart
Checkout
Home
Store
“Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
$
30.00
Add to cart
Details
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
A Discussion on the Methodologies Used to Evaluate Antidepressants
$
15.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Efficacy and Tolerability of Controlled-Release Paroxetine
$
30.00
Add to cart
Details
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
$
30.00
Add to cart
Details
Intermittent Fluoxetine Dosing in the Treatment of Women With Premenstrual Dysphoria
$
30.00
Add to cart
Details
Neuropharmacology of Paroxetine
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Add to cart
Details
Comparing the Methods Used to Compare Antidepressants
$
30.00
Add to cart
Details
Remission: Today’s Target in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Recent Advances in the Neurobiology of Depression
$
30.00
Add to cart
Details
New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
Previous
1
…
4
5
6
…
44
Next
Page load link
Go to Top
